+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)


Global Peripheral Arterial Diseases Market Research and Forecast, 2018-2023

  • ID: 4751435
  • Report
  • February 2019
  • Region: Global
  • Orion Market Research Private Limited
until Dec 31st 2021


  • Abbott Laboratories
  • B. Braun Melsungen AG
  • Boston Scientific Corp.
  • Cook Group Inc.
  • Merit Medical Systems
  • Spectranetics Corp.
  • MORE
Peripheral artery disease (PAD) is a condition that occurs when extra cholesterol and other fats collect in the walls of the arteries. This extra build-up which is commonly known as plaque narrows a patient artery and reduces the flow of blood. The rising prevalence of PAD has been the major factor driving the market growth. For instance, according to Centres for Disease Control and Prevention (CDC), around 8.5 million people in the US are suffering from PAD, among which nearly 12%-20% of individuals are more than 60 years old. Rising geriatric population and high prevalence of this disease in older age group have been motivating the market. Additionally, a large number of market players offering a broad portfolio of devices and cohesive government policies is positively impacting the growth of the market.

Certain factors such as high cost of PAD treatment along with lack of reimbursement policies in low-income countries acts a major restraining factor in the growth of the global PAD market. Additionally, lack of awareness towards PAD diagnosis and treatment in underdeveloped countries hinders the market growth. However, rising healthcare infrastructure in emerging economies such as China and India, are anticipated to further drive the market growth. Moreover, a strong pipeline of drugs for these diseases creates a significant contribution to the growth of the PAD market across the globe.

North America has been estimated as the highest market shareholder in the global PAD market due to high awareness among the population towards the PAD diagnosis and treatment. Additionally, the growing geriatric population and advanced drug discovery for these diseases in the region motivates the PAD market. Moreover, APAC region has been predicted as the fastest growing region in the global PAD market due to rapidly developing healthcare infrastructure and medical tourism in the region. For instance, government initiatives have affected the price of stents in India, which promotes its adoption and enable market growth in the country.

The key players operating in the global PAD market include Abbott Laboratories, Boston Scientific Corp., Bayer AG, VOLCANO CORP., Medtronic, PLC, and Cook Group Inc., among others. R&D, Partnership, product launch, and collaboration are the key winning strategies adopted by market players across the globe.

Research Methodology

The market study of PAD market is incorporated by extensive primary and secondary research. Secondary research has been conducted to refine the available data to break down the market in various segments, derive total market size, market forecast, and growth rate. Different approaches have been worked on to derive the market value and market growth rate. The publisher collects facts and data related to the market from different geographies to provide a better regional outlook. In the report, the country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior and macroeconomic factors. The numbers extracted from secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables the analysts to derive the closest possible figures without any major deviations in the actual number. Our analysts try to contact as many executives, managers, key opinion leaders, and industry experts to get first-hand information. Primary research brings authenticity to our reports.

Secondary Sources Include
  • Financial reports of companies involved in the market
  • Authentic Public Databases such as the American Heart Association, Society for Vascular Surgery, and others
  • Whitepapers, research-papers and news blogs
  • Company websites and their product catalog
The report is intended for hospitals and surgical centers, diagnostics laboratories for overall market analysis and competitive analysis. The report provides an in-depth analysis of market size and will serve as a source for 360-degree analysis of the market thoroughly delivering insights into the market for better business decisions.

Market Segmentation

Global peripheral arterial diseases market is segmented on the basis of regional outlook and following segments:
  • Global Peripheral Arterial Diseases Market Research and Analysis by Treatment Device
  • Global Peripheral Arterial Diseases Market Research and Analysis by Drugs
  • Global Peripheral Arterial Diseases Market Research and Analysis by End-Users
  • Global Peripheral Arterial Diseases Market Research and Analysis by Region
The Report Covers
  • Comprehensive research methodology of global PAD market.
  • This report also includes a detailed and extensive market overview with analyst insights & key market trends.
  • An exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
  • Analysis of regional regulations and other government policies impacting the global PAD market.
  • Insights about market determinants which are stimulating the global PAD market.
  • Detailed and extensive market segments with regional distribution of forecasted revenues.
  • Extensive profiles and recent developments of market players.
Note: Product cover images may vary from those shown


  • Abbott Laboratories
  • B. Braun Melsungen AG
  • Boston Scientific Corp.
  • Cook Group Inc.
  • Merit Medical Systems
  • Spectranetics Corp.
  • MORE
1.1. Research Methods and Tools
1.2. Market Breakdown
1.2.1. By Segments
1.2.2. By Geography
1.2.3. By Stakeholders

2.1. Definition
2.2. Analyst Insights &Current Market Trends
2.2.1. Key Findings
2.2.2. Recommendation
2.2.3. Conclusion
2.3. Rules & Regulations

3.1. Motivators
3.1.1. Rising Demand for Minimally-Invasive Procedures
3.1.2. Increase in Incidence Rate of Peripheral Arterial Diseases
3.1.3. Presence of Large Patient Pool with Unmet Medical Needs
3.1.4. Sedentary Lifestyle and Faulty Dietary Habits
3.2. Restraints
3.2.1. High Cost of Treatment
3.2.2. Lack of Reimbursement Policies
3.2.3. Low Awareness regarding Peripheral Arterial Diseases in Underdeveloped Economies
3.3. Opportunities
3.3.1. Strong Pipeline for Drugs Such as Clopidogrel and Rivaroxaban
3.3.2. Rising Healthcare Expenditure in Emerging Economies

4.1. Global Peripheral Artery Diseases Market by Treatment Device
4.1.1. Peripheral Vascular Stents
4.1.2. Peripheral Transluminal Angioplasty Balloon Catheters
4.1.3. PTA Guidewires
4.1.4. Atherectomy Devices
4.1.5. Chronic Total Occlusion Devices
4.1.6. Aortic Stents
4.1.7. Synthetic Surgical Grafts
4.1.8. Others (Embolic Protection Devices and Inferior Vena Cava Filters)
4.2. Global Peripheral Artery Diseases Market by Drugs
4.2.1. Cholesterol-Lowering Drugs
4.2.2. High Blood Pressure Lowering Drug
4.2.3. Blood Sugar Regulating Drug
4.2.4. Blood Clot Preventing Drug
4.3. Global Peripheral Artery Diseases Market by End-Users
4.3.1. Hospitals and Clinics
4.3.2. Diagnostic Centres
4.3.3. Research Institutes

5.1. Key Strategy Analysis
5.2. Key Company Analysis
5.3. Pipeline Analysis
5.3.1. Rivaroxaban
5.3.2. DLBS1033
5.3.3. Clopidogrel (SR25990)
5.3.4. Propionyl-L-Caritine
5.3.5. Others

6.1. North America
6.1.1. United States
6.1.2. Canada
6.2. Europe
6.2.1. UK
6.2.2. France
6.2.3. Germany
6.2.4. Italy
6.2.5. Spain
6.2.6. RoE
6.3. Asia-Pacific
6.3.1. India
6.3.2. China
6.3.3. Japan
6.3.4. Rest of Asia-Pacific
6.4. Rest of the World (RoW)

7.1. Abbott Laboratories
7.2. AngioDynamics, Inc.
7.3. AstraZeneca PLC
7.4. B. Braun Melsungen AG
7.5. Bayer AG
7.6. Biotronik, Inc.
7.7. Boston Scientific Corp.
7.8. C. R. Bard, Inc.
7.9. Cardinal Health, Inc.
7.10. CardioVascular BioTherapeutics, Inc.
7.11. Cook Group Inc.
7.12. Edwards Lifesciences Corp.
7.13. ENDOCOR GmbH
7.14. Johnson & Johnson Services, Inc.
7.15. Medtronic, PLC
7.16. Merit Medical Systems
7.17. Sanofi SA
7.18. Shockwave Medical Inc.
7.19. Spectranetics Corp.
7.20. Terumo Corp.
7.21. VentureMed Group, Inc
7.22. Volcano Corp.
Note: Product cover images may vary from those shown

A selection of companies mentioned in this report includes:

  • Abbott Laboratories
  • AngioDynamics, Inc.
  • AstraZeneca PLC
  • B. Braun Melsungen AG
  • Bayer AG
  • Biotronik, Inc.
  • Boston Scientific Corp.
  • C. R. Bard, Inc.
  • Cardinal Health, Inc.
  • CardioVascular BioTherapeutics, Inc.
  • Cook Group Inc.
  • Edwards Lifesciences Corp.
  • Johnson & Johnson Services, Inc.
  • Medtronic, PLC
  • Merit Medical Systems
  • Sanofi SA
  • Shockwave Medical Inc.
  • Spectranetics Corp.
  • Terumo Corp.
  • VentureMed Group, Inc
  • Volcano Corp.
Note: Product cover images may vary from those shown